Fadaka, Adewale OluwaseunSibuyi, Nicole Remaliah SamanthaMadiehe, Abram Madimabe2023-02-082023-02-082022Fadaka, A. O. et al. (2022). Computational insight of dexamethasone against potential targets of SARS-CoV-2. JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS, 40 (2). 875-885. 10.1080/07391102.2020.18198801538-025410.1080/07391102.2020.1819880http://hdl.handle.net/10566/8376The health sector has been on the race to find a potent therapy for coronavirus disease (COVID)-19, a diseases caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2. Repurposed anti-viral drugs have played a huge role in combating the virus, and most recently, dexamethasone (Dex) have shown its therapeutic activity in severe cases of COVID-19 patients. The study sought to provide insights on the anti-COVID-19 mechanism of Dex at both atomic and molecular level against SARSCoV-2 targets. Computational methods were employed to predict the binding affinity of Dex to SARSCoV-2 using the Schrodinger suite (v2020-2). The target molecules and ligand (Dex) were retrieved from PDB and PubChem, respectively. The selected targets were SARS-CoV-2 main protease (Mpro), and host secreted molecules glucocorticoid receptor, and Interleukin-6 (IL-6). Critical analyses such as Protein and ligand preparation, molecular docking, molecular dynamic (MD) simulations, and absorption, distribution, metabolism, excretion (ADME), and toxicity analyses were performed using the targets and the ligand as inputs.enDexamethasoneCovid-19Public healthWorld Health Organization (WHO)BiotechnologyArticle